We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$11.1B
AUM Growth
-$771M
Cap. Flow
-$1.01B
Cap. Flow %
-9.11%
Top 10 Hldgs %
9.6%
Holding
1,240
New
103
Increased
332
Reduced
508
Closed
87

Sector Composition

Rank Sector Weight
1 Industrials 29.26%
2 Technology 17.08%
3 Financials 13.64%
4 Consumer Discretionary 12.84%
5 Materials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UGI icon
551
UGI
UGI
$8.11B
$3.92M 0.04%
73,400
PRMW
552
DELISTED
Primo Water Corporation
PRMW
$3.91M 0.04%
318,040
-82,000
-20% -$1.1M
SKY icon
553
Champion Homes
SKY
$4.59B
$3.9M 0.04%
142,400
FAF icon
554
First American
FAF
$7.44B
$3.89M 0.04%
72,412
-2,106
-3% -$115K
QLYS icon
555
Qualys
QLYS
$6.41B
$3.89M 0.04%
44,664
+8,626
+24% +$744K
CLCT
556
DELISTED
Collectors Universe
CLCT
$3.85M 0.03%
180,399
-176
-0.1% -$3.36K
LARK icon
557
Landmark Bancorp
LARK
$203M
$3.85M 0.03%
226,163
-2,070
-0.9% -$35.2K
FSS icon
558
Federal Signal
FSS
$6.9B
$3.84M 0.03%
143,573
-154,962
-52% -$4.06M
ZUO
559
DELISTED
Zuora, Inc.
ZUO
$3.8M 0.03%
+248,000
New +$4.7M
ICD
560
DELISTED
Independence Contract Drilling, Inc.
ICD
$3.8M 0.03%
120,235
+5,664
+5% +$277K
HLNE icon
561
Hamilton Lane
HLNE
$5.13B
$3.78M 0.03%
66,288
-3,500
-5% -$176K
EGRX
562
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.77M 0.03%
67,633
+3,150
+5% +$164K
CTT
563
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$3.76M 0.03%
359,658
+67,000
+23% +$666K
NWHM
564
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$3.72M 0.03%
966,711
+144,713
+18% +$659K
MAG
565
DELISTED
MAG Silver
MAG
$3.72M 0.03%
352,950
GAIA icon
566
Gaia
GAIA
$32.5M
$3.71M 0.03%
489,400
-201,900
-29% -$1.7M
HBIO icon
567
Harvard Bioscience
HBIO
$36.4M
$3.66M 0.03%
182,980
+9,960
+6% +$292K
LOW icon
568
Lowe's Companies
LOW
$109B
$3.63M 0.03%
36,000
+1,500
+4% +$158K
ZUMZ icon
569
Zumiez
ZUMZ
$209M
$3.63M 0.03%
+139,200
New +$3.38M
VALU icon
570
Value Line
VALU
$370M
$3.63M 0.03%
131,974
WST icon
571
West Pharmaceutical
WST
$25.7B
$3.63M 0.03%
29,000
NPTN
572
DELISTED
NEOPHOTONICS CORP
NPTN
$3.63M 0.03%
867,279
-1,297,980
-60% -$6.84M
FFG
573
DELISTED
FBL Financial Group
FFG
$3.62M 0.03%
56,790
+16,990
+43% +$1.08M
MG icon
574
Mistras Group
MG
$626M
$3.61M 0.03%
251,293
+249,193
+11,866% +$3.43M
BKE icon
575
Buckle
BKE
$2.04B
$3.6M 0.03%
207,675
-21,652
-9% -$381K

Similar funds

Royce & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Royce & Associates held 1,240 positions worth $11.1B, down 6.5% from $11.8B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates withdrew a net $1.01B in Q2 2019, closing 87 positions and reducing 508 holdings. Its most notable exit was Universal Corp, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 30% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in G-III Apparel Group worth $12.6M.

  • Royce & Associates's largest Q2 2019 buy was G-III Apparel Group: 426,975 shares worth $12.6M.
  • Royce & Associates added most to Verso Corporation in Q2 2019, an estimated $18.6M increase.
  • Royce & Associates's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $72.7M.
  • Royce & Associates fully exited Universal Corp in Q2 2019, selling an estimated $17.7M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $11.1B portfolio in Q2 2019.
  • Royce & Associates opened 103 new positions and closed 87 in Q2 2019.
  • Royce & Associates's portfolio value fell 6.5% quarter-over-quarter to $11.1B.

Based on Royce & Associates's 13F filing for Q2 2019, filed 12 Aug 2019.